Literature DB >> 11127818

The isoform-specific stretch of hSos1 defines a new Grb2-binding domain.

N Zarich1, J L Oliva, R Jorge, E Santos, J M Rojas.   

Abstract

hSos1 isoform II, defined by the presence of a 15 amino acid stretch in its carboxy-terminal region, exhibits higher Grb2 affinity than hSos1 isoform I. In this study, we investigated the cause for this difference and observed that, in addition to the four currently accepted Grb2-binding motifs, a number of additional, putative SH3-minimal binding sites (SH3-MBS) could be identified. The isoform II-specific 15 amino acid stretch contained one of them. Indeed, we demonstrated by site-directed mutagenesis that these SH3-MBS were responsible for the Grb2 interaction, and we found that C-terminal fragments of the two hSos1 isoforms (lacking the four cannonical Grb2-binding motifs, but containing the SH3-minimal binding sites) were able to bind Grb2, with the isoform II fragment showing higher Grb2 affinity than the corresponding isoform I fragment. Furthermore, we provide evidence that C-terminal truncated mutants of either hSos1 isoform, containing only the SH3-minimal binding sites, were able to originate in vivo stable complexes with Grb2. Although, Grb2-binding remains higher in both full-length isoforms, compared to the C-terminal truncated mutants, these mutants were also able to activate Ras, supporting a potential role of this C-terminal region as negative modulator of Sos1 activity. These findings document the existence of a new, functional, SH3-minimal binding site located in the specific stretch of hSos1 isoform II which may be responsible for the increased Grb2 affinity of this isoform in comparison to isoform I, and for the physiological properties differences between both isoforms. Moreover, these SH3-minimal binding sites may be sufficient to attain stable and functional hSosl-Grb2 complexes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127818     DOI: 10.1038/sj.onc.1203955

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.

Authors:  Jose Luis Oliva; Dolores Pérez-Sala; Antonio Castrillo; Natalia Martínez; F Javier Cañada; Lisardo Boscá; José M Rojas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-08       Impact factor: 11.205

2.  Grb2 is a negative modulator of the intrinsic Ras-GEF activity of hSos1.

Authors:  Natasha Zarich; José Luis Oliva; Natalia Martínez; Rocío Jorge; Alicia Ballester; Silvia Gutiérrez-Eisman; Susana García-Vargas; José M Rojas
Journal:  Mol Biol Cell       Date:  2006-06-07       Impact factor: 4.138

3.  Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.

Authors:  José M Rojas; José Luis Oliva; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

4.  p27Kip1 inhibition of GRB2-SOS formation can regulate Ras activation.

Authors:  Stephanie J Moeller; Elizabeth D Head; Robert J Sheaff
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Sprouty2 and Spred1-2 proteins inhibit the activation of the ERK pathway elicited by cyclopentenone prostanoids.

Authors:  Carlota A García-Domínguez; Natalia Martínez; Teresa Gragera; Andrea Pérez-Rodríguez; Diana Retana; Gonzalo León; Agustín Sánchez; José Luis Oliva; Dolores Pérez-Sala; José M Rojas
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

6.  A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders.

Authors:  Maria Rita Gulotta; Riccardo Brambilla; Ugo Perricone; Andrea Brancale
Journal:  Pharmaceuticals (Basel)       Date:  2021-10-28

7.  PGA1-induced apoptosis involves specific activation of H-Ras and N-Ras in cellular endomembranes.

Authors:  B Anta; A Pérez-Rodríguez; J Castro; C A García-Domínguez; S Ibiza; N Martínez; L M Durá; S Hernández; T Gragera; D Peña-Jiménez; M Yunta; N Zarich; P Crespo; J M Serrador; E Santos; A Muñoz; J L Oliva; J M Rojas-Cabañeros
Journal:  Cell Death Dis       Date:  2016-07-28       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.